Answers are grounded in this paper and cite their sources.
Skytte A-B, Crüger D, Gerster M, Lænkholm A-V, Lang C, Brøndum-Nielsen K, Andersen MK, Sunde L, Kølvraa S, Gerdes A-M. Breast cancer after bilateral risk-reducing mastectomy. This study aims to evaluate the incidence of breast cancer after risk-reducing mastectomy (RRM) in healthy BRCA mutation carriers. This study is a long-term follow-up of 307 BRCA mutation carriers of whom 96 chose RRM. None of the study participants had a previous history of breast or ovarian cancer nor had they undergone RRM or risk-reducing bilateral salpingo-oophorectomy (BSO) prior to the time of BRCA testing. The annual incidence of post-mastectomy breast cancer was 0.8% compared with 1.7% in the non-operated group. Implications of these findings in relation to genetic counseling and future management are discussed.
No takes yet. Share an insight, caveat, or question.
Crüger et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: